Amexdrug Corporation (AXRX)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jun 6, 2025
Amexdrug Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | 2003 - 2007 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '13 Jun 30, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 | 2003 - 2007 |
| Net Income | 0.17 | 0.08 | 0.1 | 0.19 | 0.02 | 0.01 | Upgrade
|
| Depreciation & Amortization | 0.05 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0 | -0 | 0 | 0 | 0 | 0 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.02 | -0.01 | -0.02 | 0 | 0.01 | 0.02 | Upgrade
|
| Other Operating Activities | - | - | -0 | 0.03 | - | -0 | Upgrade
|
| Change in Accounts Receivable | -0.11 | 0.11 | -0.16 | -0.05 | -0.13 | -0.13 | Upgrade
|
| Change in Inventory | -0.25 | -0.6 | 0.11 | -0.18 | 0.05 | -0.02 | Upgrade
|
| Change in Accounts Payable | 0.02 | 0.21 | -0.07 | 0.15 | -0.03 | -0.09 | Upgrade
|
| Change in Income Taxes | 0.06 | - | -0.11 | 0.1 | -0 | 0.01 | Upgrade
|
| Change in Other Net Operating Assets | -0.05 | -0.03 | -0.04 | 0.01 | -0 | -0.01 | Upgrade
|
| Operating Cash Flow | -0.07 | -0.16 | -0.14 | 0.23 | -0.06 | -0.19 | Upgrade
|
| Capital Expenditures | -0.46 | -0.46 | -0.04 | -0 | -0.01 | -0 | Upgrade
|
| Investment in Securities | 0 | -0 | 0 | -0 | -0.01 | -0 | Upgrade
|
| Investing Cash Flow | -0.46 | -0.46 | -0.04 | -0 | -0.02 | -0.01 | Upgrade
|
| Short-Term Debt Issued | - | 0.07 | 0.32 | 0.11 | 0.11 | 0.1 | Upgrade
|
| Long-Term Debt Issued | - | 0.39 | - | - | - | - | Upgrade
|
| Total Debt Issued | 0.81 | 0.46 | 0.32 | 0.11 | 0.11 | 0.1 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -0 | -0.01 | Upgrade
|
| Total Debt Repaid | -0.2 | - | - | - | -0 | -0.01 | Upgrade
|
| Net Debt Issued (Repaid) | 0.61 | 0.46 | 0.32 | 0.11 | 0.11 | 0.08 | Upgrade
|
| Repurchase of Common Stock | -0 | -0 | -0 | -0 | -0.01 | - | Upgrade
|
| Other Financing Activities | -0.01 | -0.01 | 0 | -0 | 0 | -0.01 | Upgrade
|
| Financing Cash Flow | 0.59 | 0.45 | 0.32 | 0.1 | 0.11 | 0.08 | Upgrade
|
| Net Cash Flow | 0.06 | -0.17 | 0.15 | 0.32 | 0.02 | -0.12 | Upgrade
|
| Free Cash Flow | -0.54 | -0.62 | -0.18 | 0.22 | -0.07 | -0.2 | Upgrade
|
| Free Cash Flow Margin | -5.85% | -6.77% | -1.45% | 1.94% | -0.75% | -3.44% | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | 0.00 | - | -0.00 | Upgrade
|
| Cash Interest Paid | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | Upgrade
|
| Cash Income Tax Paid | 0.05 | 0.05 | 0.03 | 0.01 | 0 | 0.01 | Upgrade
|
| Levered Free Cash Flow | -0.53 | -0.61 | -0.15 | 0.2 | -0.07 | -0.2 | Upgrade
|
| Unlevered Free Cash Flow | -0.5 | -0.58 | -0.13 | 0.21 | -0.06 | -0.19 | Upgrade
|
| Change in Net Working Capital | 0.3 | 0.27 | 0.23 | -0.03 | 0.09 | 0.22 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.